VMBIP E-newsletter, December 5, 2008
VMBIP Updates

•	To date, we have been informed of providers from three different grantee jurisdictions that have returned used syringes with uncapped needles to McKesson.  This is a very serious safety concern.  Please be sure to read the stand alone all-grantee message that will be distributed today (Friday, December 5).  Thank you in advance for your efforts to communicate with your providers about this issue as soon as possible.
•	Please be sure to read the stand alone all-grantee message that will be distributed today or early next week that updates and corrects McKesson's December holiday shipping schedule.
•	Merck Hepatitis A Pediatric (VAQTA) is now available to order from both Memphis and Sacramento distribution centers.  

VMBIP Performance Dashboard 

WEEKLY PERFORMANCE METRIC SCORECARD

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 11-14-08:98.3 percent  
Week Ending 11-21-08: 95.0 percent
Week Ending 11-28-08:  98.2 percent
Weighted Average Last 3 Weeks: 
Explanation:  None

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 11-14-08:  99.9 percent
Week Ending 11-21-08: 100 percent
Week Ending 11-28-08:  98.8 percent
Weighted Average Last 3 Weeks: 99.9 percent
Explanation:  None

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending 11-14-08:  99.95 percent
Week Ending 11-21-08: 99.98 percent
Week Ending 11-28-08:  99.71 percent
Weighted Average Last 3 Weeks: 99.95 percent
Explanation:  None

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending 11-14-08:  98.66 percent
Week Ending 11-21-08: 99.37 percent
Week Ending 11-28-08:  96.50 percent
Weighted Average Last 3 Weeks: 98.87 percent
Explanation:  None

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending 11-14-08:  100 percent
Week Ending 11-21-08: 99.99 percent
Week Ending 11-28-08:  99.95 percent
Weighted Average Last 3 Weeks: 99.99 percent
Explanation:  None

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending 11-14-08:  100 percent
Week Ending 11-21-08: 100 percent
Week Ending 11-28-08:  100 percent
Weighted Average Last 3 Weeks: 100 percent
Explanation:  None

F
Metric: State Funded PO Transmission
Week Ending 11-14-08:  100 percent
Week Ending 11-21-08: 100 percent
Week Ending 11-28-08:  100 percent
Weighted Average Last 3 Weeks: 100 percent
Explanation:  None

Key
A. 
Percent of provider orders shipped within 3 days of McKesson receiving order from CDC: removes all lines of product on backorder (backorders or over-allocation) - an order is defined as all vaccines requested by a provider on a given day: a line (order line) is defined as the individual vaccines that make up the order		

B. 
Percent of provider orders shipped within 5 days of McKesson receiving order from CDC: removes all lines of product on backorder (backorders or over-allocation)	

C1. 
Percent of provider orders delivered with viable vaccine: excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable/customer not available, or carrier damageC2. Percent of provider orders delivered with viable vaccine: includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address/delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 

D.  
Percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	

E.  
Percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and transmits to CDC within 24 (flu) / 48 (other) hrs of delivery by manufacturer	

F.  
Percent of grantee replenishment orders McKesson faxes/e-mails receipt to grantees within 48 hrs of delivery by manufacturer

Vaccines on allocation HIB and FLU: 
Vaccines on manufacturer shortage Merck Hep A
Vaccines placed on backorder during the most recent week: TD (580 doses) – incorrect NDC ordered.  Orders will be cancelled and new orders submitted for the correct NDC

VMBIP Performance Dashboard – Shipping Metrics by Distribution Center
Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 11-14-08:  97.8 percent
Week Ending 11-21-08: 93.2 percent
Week Ending 11-28-08:  97.9 percent
Weighted Average Last 3 Weeks: 95.7 percent
Explanation:  None

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)

Week Ending 11-14-08:  99.9 percent
Week Ending 11-21-08: 100 percent
Week Ending 11-28-08:  98.6 percent
Weighted Average Last 3 Weeks: 99.8 percent
Explanation:  None

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 11-14-08:  99.7 percent
Week Ending 11-21-08: 99.7 percent
Week Ending 11-28-08:  100 percent
Weighted Average Last 3 Weeks: 99.7 percent
Weighted Average Last 3 Weeks: 95.7 percent
Explanation:  None

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 11-14-08:  99.9 percent
Week Ending 11-21-08: 100 percent
Week Ending 11-28-08:  100 percent
Weighted Average Last 3 Weeks: 99.9 percent
Explanation: None

Key
A. 
Percent of provider orders shipped within 3 days of McKesson receiving order from CDC: removes all lines of product on backorder (backorders or over-allocation) - an order is defined as all vaccines requested by a provider on a given day: a line (order line) is defined as the individual vaccines that make up the order
		
B. 
Percent of provider orders shipped within 5 days of McKesson receiving order from CDC: removes all lines of product on backorder (backorders or over-allocation)

As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov or Julie Orta jio7@cdc.gov, with a cc to your project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/downloads/newsletters/vmbip-nl-12-05-08.rtf